Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameDenintuzumab Biosimilar - Anti-CD19 mAb - Research Grade
SourceCAS 1399672-02-6
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDenintuzumab,SGN-19A,SGN-CD19A,hBU12-491,unconjugated:huBU12,CD19,anti-CD19
ReferencePX-TA1348
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Denintuzumab Biosimilar - Anti-CD19 mAb - Research Grade

General information on Anti-CD19[Homo sapiens] (Denintuzumab) Monoclonal Antibody

Denintuzumab has been infestigated in the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD19 Protein – Human CD19 recombinant protein
Antigen

CD19 Protein – Human CD19 recombinant protein

PX-P4004 210€
CD19 Recombinant Protein
Antigen

CD19 Recombinant Protein

PX-P4077 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products